Guolan Lu

Guolan Lu

Auto-generated profile, based on publicly available information

Guolan Lu

Department of Otolaryngology, Stanford University School of Medicine, 900 Blake Wilbur Drive, Stanford, CA 94305, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
GLGuolan Lu
Guolan Lu
BFBaowei Fei
Baowei Fei
Hyperspectral imaging (HSI) is an emerging imaging modality for medical applications, especially in disease diagnosis and image-guided surgery. HSI acquires a three-dimensional dataset called hypercube, with two spatial dimensions and one spectral dimension. Spatially resolved spectral imaging obtained by HSI provides diagnostic information about the tissue physiology, morphology, and composition. This review paper presents an overview of the literature on medical hyperspectral imaging technology and its applications. The aim of the survey is threefold: an introduction for those new to the field, an overview for those working in the field, and a reference for those searching for literature on a specific application.

1 June 2017 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
MHMartin Halicek
Martin Halicek
GLGuolan Lu
Guolan Lu
JLJames V. Little
James V. Little
XWXu Wang
Xu Wang
MPMihir Patel
Mihir Patel
BFBaowei Fei
Baowei Fei
Surgical cancer resection requires an accurate and timely diagnosis of the cancer margins in order to achieve successful patient remission. Hyperspectral imaging (HSI) has emerged as a useful, noncontact technique for acquiring spectral and optical properties of tissue. A convolutional neural network (CNN) classifier is developed to classify excised, squamous-cell carcinoma, thyroid cancer, and normal head and neck tissue samples using HSI. The CNN classification was validated by the manual annotation of a pathologist specialized in head and neck cancer. The preliminary results of 50 patients indicate the potential of HSI and deep learning for automatic tissue-labeling of surgical specimens of head and neck patients.

27 March 2024 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
MMMagdalena Matusiak
Magdalena Matusiak
JHJohn W. Hickey
John W. Hickey
DIDavid G.P. van Ijzendoorn
David G.P. van Ijzendoorn
GLGuolan Lu
Guolan Lu
LKLukasz Kidziński
Lukasz Kidziński
MRMatt van de Rijn
Matt van de Rijn
Tumor-associated macrophages are transcriptionally heterogeneous, but the spatial distribution and cell interactions that shape macrophage tissue roles remain poorly characterized. Here, we spatially resolve five distinct human macrophage populations in normal and malignant human breast and colon tissue and reveal their cellular associations. This spatial map reveals that distinct macrophage populations reside in spatially segregated micro-environmental niches with conserved cellular compositions that are repeated across healthy and diseased tissue. We show that IL4I1+ macrophages phagocytose dying cells in areas with high cell turnover and predict good outcome in colon cancer. In contrast, SPP1+ macrophages are enriched in hypoxic and necrotic tumor regions and portend worse outcome in colon cancer. A subset of FOLR2+ macrophages is embedded in plasma cell niches. NLRP3+ macrophages co-localize with neutrophils and activate an inflammasome in tumors. Our findings indicate that a limited number of unique human macrophage niches function as fundamental building blocks in tissue. Significance: This work broadens our understanding of the distinct roles different macrophage populations may exert on cancer growth and reveals potential predictive markers and macrophage population-specific therapy targets.

9 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
GLGuolan Lu
Guolan Lu
NNNaoki Nishio
Naoki Nishio
NBNynke S. van Den Berg
Nynke S. van Den Berg
BMBrock A. Martin
Brock A. Martin
SFShayan Fakurnejad
Shayan Fakurnejad
EREben L. Rosenthal
Eben L. Rosenthal
Poor tissue penetration remains a major challenge for antibody-based therapeutics of solid tumors, but proper dosing can improve the tissue penetration and thus therapeutic efficacy of these biologics. Due to dose-limiting toxicity of the small molecule payload, antibody-drug conjugates (ADCs) are administered at a much lower dose than their parent antibodies, which further reduces tissue penetration. We conducted an early-phase clinical trial (NCT02415881) and previously reported the safety of an antibody-dye conjugate (panitumumab-IRDye800CW) as primary outcome. Here, we report a retrospective exploratory analysis of the trial to evaluate whether co-administration of an unconjugated antibody could improve the intratumoral distribution of the antibody-dye conjugate in patients. By measuring the multiscale distribution of the antibody-dye conjugate, this study demonstrates improved microscopic antibody distribution without increasing uptake (toxicity) in healthy tissue when co-administered with the parent antibody, supporting further clinical investigation of the co-administration dosing strategy to improve the tumor penetration of ADCs.

14 August 2015 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
RPRobert Pike
Robert Pike
GLGuolan Lu
Guolan Lu
DWDongsheng Wang
Dongsheng Wang
ZCZhuo Georgia Chen
Zhuo Georgia Chen
BFBaowei Fei
Baowei Fei
Goal: The purpose of this paper is to develop a classification method that combines both spectral and spatial information for distinguishing cancer from healthy tissue on hyperspectral images in an animal model. Methods: An automated algorithm based on a minimum spanning forest (MSF) and optimal band selection has been proposed to classify healthy and cancerous tissue on hyperspectral images. A support vector machine classifier is trained to create a pixel-wise classification probability map of cancerous and healthy tissue. This map is then used to identify markers that are used to compute mutual information for a range of bands in the hyperspectral image and thus select the optimal bands. An MSF is finally grown to segment the image using spatial and spectral information. Conclusion: The MSF based method with automatically selected bands proved to be accurate in determining the tumor boundary on hyperspectral images. Significance: Hyperspectral imaging combined with the proposed classification technique has the potential to provide a noninvasive tool for cancer detection.

14 September 2017 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GLGuolan Lu
Guolan Lu
JLJames V. Little
James V. Little
XWXu Wang
Xu Wang
HZHongzheng Zhang
Hongzheng Zhang
MPMihir R. Patel
Mihir R. Patel
BFBaowei Fei
Baowei Fei
Purpose: This study intends to investigate the feasibility of using hyperspectral imaging (HSI) to detect and delineate cancers in fresh, surgical specimens of patients with head and neck cancers.Experimental Design: A clinical study was conducted in order to collect and image fresh, surgical specimens from patients (N = 36) with head and neck cancers undergoing surgical resection. A set of machine-learning tools were developed to quantify hyperspectral images of the resected tissue in order to detect and delineate cancerous regions which were validated by histopathologic diagnosis. More than two million reflectance spectral signatures were obtained by HSI and analyzed using machine-learning methods. The detection results of HSI were compared with autofluorescence imaging and fluorescence imaging of two vital-dyes of the same specimens.Results: Quantitative HSI differentiated cancerous tissue from normal tissue in ex vivo surgical specimens with a sensitivity and specificity of 91% and 91%, respectively, and which was more accurate than autofluorescence imaging (P < 0.05) or fluorescence imaging of 2-NBDG (P < 0.05) and proflavine (P < 0.05). The proposed quantification tools also generated cancer probability maps with the tumor border demarcated and which could provide real-time guidance for surgeons regarding optimal tumor resection.Conclusions: This study highlights the feasibility of using quantitative HSI as a diagnostic tool to delineate the cancer boundaries in surgical specimens, and which could be translated into the clinic application with the hope of improving clinical outcomes in the future. Clin Cancer Res; 23(18); 5426–36. ©2017 AACR.